23/06/2025 | Ghalibo (PTC) Limited | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | Future Industry Investment Fund II (Limited Partnership) (先进制造产业投资基金二期 (有限合伙)) | 1701(L) | | | 24,274,756(L) | 8.05 | 23/06/2025 | 上海金浦醫療健康股權投資基金管理有限公司 | 1701(L) | +17,153,860(L) | | 17,153,860(L) | 5.69 | 23/06/2025 | 南京药石科技股份有限公司 | 1701(L) | | | 22,107,247(L) | 7.33 | 23/06/2025 | CPEChina Fund IV, L.P. | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | CPE Investment (Hong Kong) 2021 Limited | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | Morningside Holdings (Asia) Limited | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | Morningside Venture (I) Investments Limited | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | 陳譚慶芬 | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | CPE Funds IV Limited | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | CPE Management International Limited | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | CPE Management International II Limited | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | Shanghai Guoxin Investment Development Co., Ltd. | 1701(L) | +8,314,088(L) | | 8,314,088(L) | 8.73 | 23/06/2025 | Genecare Development Limited | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | 國投創業投資管理有限公司 | 1701(L) | | | 21,680,081(L) | 7.19 | 23/06/2025 | Wu Frank | 1701(L) | +80,597,797(L) | | 80,597,797(L) | 26.72 | 23/06/2025 | Cayenne Private Enterprise IV Limited | 1701(L) | | | 21,521,091(L) | 22.60 | 23/06/2025 | Nanjing Jiminrui Biotech Partnership (Limited Partnership) | 1701(L) | +22,896,756(L) | | 22,896,756(L) | 24.04 | 23/06/2025 | Nanjing Yipu Bioscience Technology Partnership (Limited Partnership) | 1701(L) | +27,363,076(L) | | 27,363,076(L) | 9.07 | 23/06/2025 | Nanjing Yipu Bioscience Technology Partnership (Limited Partnership) | 1701(L) | +27,363,076(L) | | 27,363,076(L) | 28.73 | 23/06/2025 | Morningside Bio-Ventures Limited | 1701(L) | | | 27,610,879(L) | 9.15 | 23/06/2025 | Wu Frank | 1701(L) | +50,259,832(L) | | 50,259,832(L) | 52.78 | | 1 |
|